Riskpilot← Back to searchSign inGet full accessNEVE INVEST ApS
APSActiveCVR 35480757Ellevænget 4Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2013— employees
Revenue 2025
DKK 0
EBITDA margin
—
Equity ratio
-38.8%
Financial strength
Net profit 2025
DKK -1K
+92% vs 2024
| Revenue | DKK 0 | — |
| EBITDA | DKK 0 | — |
| Net profit | DKK -1K | +92% |
| Total assets | DKK 296K | +0% |
| Equity | DKK -115K | -1% |
| Employees | — | — |
Legal name
NEVE INVEST ApS
CVR number
35480757
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
25. september 2013
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én (1) direktør alene.
Company purpose
Selskabet har til formål at tegne, købe, eje og administrere kapitalandele i et eller flere selskaber med begrænset hæftelse samt at administrere og investere udbyttebetalinger fra sådanne. Investeringer kan foretages i fast ejendom, værdipapirer og andre aktiver efter det centrale ledelsesorgans skøn.
Address
Ellevænget 4
Email
blizzardcph@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -10 | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -10 | 0 | 0 | 0 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -10 | 0 | 0 | 0 | 0 |
| Net financials | -12 | -11 | -13 | -17 | -1 |
| Profit before tax | -22 | -11 | -13 | -17 | -1 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -22 | -11 | -13 | -17 | -1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 295 | 295 | 297 | 296 | 296 |
| Equity | -71 | -83 | -98 | -113 | -115 |
| Long-term debt | 10 | 0 | 0 | 0 | 0 |
| Short-term debt | 356 | 378 | 395 | 409 | 411 |
| Total debt | 366 | 378 | 395 | 409 | 411 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
-38.8%
This company
38.2%
Market median
-202% vs market
20212025
Return on equity
-131900.0%
This company
18.4%
Market median
-716948% vs market
20212025
Net profit margin
-131900.0%
This company
8.1%
Market median
-1628495% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
3.58×
This company
0.62×
Market median
-477% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25–33.32% | 25–33.32% | 2013 | |
| Individual | 25–33.32% | 25–33.32% | 2013 | |
| Individual | 25–33.32% | 25–33.32% | 2013 | |
| Individual | 25–33.32% | 25–33.32% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NEVE INVEST ApS 
DEFENSIN THERAPEUTICS ApSBoard members of NEVE INVEST ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|